Stockreport

AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

AIM ImmunoTech Inc.  (AIM) 
PDF OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief E [Read more]